Medicover Balance Sheet Health
Financial Health criteria checks 1/6
Medicover has a total shareholder equity of €527.4M and total debt of €642.7M, which brings its debt-to-equity ratio to 121.9%. Its total assets and total liabilities are €2.1B and €1.5B respectively. Medicover's EBIT is €83.3M making its interest coverage ratio 1.6. It has cash and short-term investments of €77.2M.
Key information
121.9%
Debt to equity ratio
€642.70m
Debt
| Interest coverage ratio | 1.6x |
| Cash | €77.20m |
| Equity | €527.40m |
| Total liabilities | €1.53b |
| Total assets | €2.06b |
Recent financial health updates
Medicover (STO:MCOV B) Has A Pretty Healthy Balance Sheet
Mar 05
Does Medicover (STO:MCOV B) Have A Healthy Balance Sheet?
Dec 02Medicover (STO:MCOV B) Has A Somewhat Strained Balance Sheet
Aug 21Is Medicover (STO:MCOV B) Using Too Much Debt?
May 12Is Medicover (STO:MCOV B) Using Too Much Debt?
Jan 30Does Medicover (STO:MCOV B) Have A Healthy Balance Sheet?
Oct 16Recent updates
The Strong Earnings Posted By Medicover (STO:MCOV B) Are A Good Indication Of The Strength Of The Business
Nov 07Here's What To Make Of Medicover's (STO:MCOV B) Decelerating Rates Of Return
Oct 24Investors Appear Satisfied With Medicover AB (publ)'s (STO:MCOV B) Prospects
Apr 22Additional Considerations Required While Assessing Medicover's (STO:MCOV B) Strong Earnings
Apr 04Medicover (STO:MCOV B) Has A Pretty Healthy Balance Sheet
Mar 05Medicover AB (publ)'s (STO:MCOV B) Intrinsic Value Is Potentially 31% Above Its Share Price
Feb 11Returns On Capital At Medicover (STO:MCOV B) Paint A Concerning Picture
Dec 20Does Medicover (STO:MCOV B) Have A Healthy Balance Sheet?
Dec 02Medicover's (STO:MCOV B) Returns On Capital Not Reflecting Well On The Business
Sep 12Medicover (STO:MCOV B) Has A Somewhat Strained Balance Sheet
Aug 21Is There An Opportunity With Medicover AB (publ)'s (STO:MCOV B) 37% Undervaluation?
Jun 12Medicover (STO:MCOV B) Will Want To Turn Around Its Return Trends
May 27Is Medicover (STO:MCOV B) Using Too Much Debt?
May 12Returns On Capital At Medicover (STO:MCOV B) Have Hit The Brakes
Feb 16Is Medicover (STO:MCOV B) Using Too Much Debt?
Jan 30Is Medicover AB (publ) (STO:MCOV B) Potentially Undervalued?
Dec 30Estimating The Fair Value Of Medicover AB (publ) (STO:MCOV B)
Dec 17Medicover (STO:MCOV B) Might Have The Makings Of A Multi-Bagger
Oct 30Does Medicover (STO:MCOV B) Have A Healthy Balance Sheet?
Oct 16Should You Think About Buying Medicover AB (publ) (STO:MCOV B) Now?
Sep 09Estimating The Intrinsic Value Of Medicover AB (publ) (STO:MCOV B)
Jul 25Medicover (STO:MCOV B) Has A Pretty Healthy Balance Sheet
Jul 12Investors Met With Slowing Returns on Capital At Medicover (STO:MCOV B)
Jun 13At kr179, Is It Time To Put Medicover AB (publ) (STO:MCOV B) On Your Watch List?
May 29Financial Position Analysis
Short Term Liabilities: MCOV B's short term assets (€422.0M) do not cover its short term liabilities (€564.0M).
Long Term Liabilities: MCOV B's short term assets (€422.0M) do not cover its long term liabilities (€963.8M).
Debt to Equity History and Analysis
Debt Level: MCOV B's net debt to equity ratio (107.2%) is considered high.
Reducing Debt: MCOV B's debt to equity ratio has increased from 70.9% to 121.9% over the past 5 years.
Debt Coverage: MCOV B's debt is well covered by operating cash flow (37.4%).
Interest Coverage: MCOV B's interest payments on its debt are not well covered by EBIT (1.6x coverage).